Lexaria Attending the BIO International Convention, as Part of a Broader Business Development Program Biotech Investing
Cellares and TScan Therapeutics Announce Agreement to Evaluate Automated Manufacturing of TSC-101 for Patients with Hematologic Malignancies Life Science Investing
AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026 Life Science Investing
Maravai LifeSciences Announces Refinancing of Credit Agreement, Extending Maturity to 2032 Life Science Investing
NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock Life Science Investing
CytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer Life Science Investing
Gossamer Bio, Inc. Announces Early Tender Results and Early Settlement for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes Life Science Investing
Prime Medicine to Present at Goldman Sachs 47th Annual Global Healthcare Conference Life Science Investing
Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD?L1/VEGF?A Bispecific Immunomodulator to Treat Kidney Cancer Life Science Investing
